• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不限制钠摄入且不完全清除过多液体治疗腹水的优势。

Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid.

作者信息

Reynolds T B, Lieberman F L, Goodman A R

出版信息

Gut. 1978 Jun;19(6):549-53. doi: 10.1136/gut.19.6.549.

DOI:10.1136/gut.19.6.549
PMID:680588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1412015/
Abstract

Two modifications of the standard method of treatment of ascites in chronic liver disease were investigated in three separate randomised trials involving a total of 201 patients. These modifications were (1) an unrestricted sodium intake and (2) limitation of diuresis to partial removal of ascites, to the point of relief of abdominal tension. Mean serum sodium fell significantly in all patient groups receiving the low sodium diet and did not fall in the groups given an unrestricted diet. Mean serum urea nitrogen rose significantly in the patient groups undergoing complete diuresis and did not change in the groups undergoing partial diuresis. Mean serum uric acid rose only in the groups undergoing complete diuresis. We concluded that the advantages of these two modifications of therapy of ascites were increased dietary palatability and decreased likelihood of hyponatraemia and of rise in serum urea nitrogen and uric acid. Disadvantages included dissatisfaction of patients over incomplete clearing of ascites, occasional difficulty in performing diagnostic studies because of prolonged ascites, and unsuitability of a high sodium intake in patients whose ascites is highly refractory to treatment.

摘要

在三项独立的随机试验中,对慢性肝病腹水标准治疗方法的两种改良方法进行了研究,共有201名患者参与。这些改良方法为:(1)钠摄入不受限制;(2)将利尿限制在部分消除腹水,达到缓解腹部张力的程度。接受低钠饮食的所有患者组血清钠均值显著下降,而给予无限制饮食的组血清钠均值未下降。进行完全利尿的患者组血清尿素氮均值显著升高,而进行部分利尿的组血清尿素氮均值未改变。仅进行完全利尿的组血清尿酸升高。我们得出结论,这两种腹水治疗改良方法的优点是饮食适口性增加,低钠血症以及血清尿素氮和尿酸升高的可能性降低。缺点包括患者对腹水未完全清除不满意,因腹水持续时间长偶尔难以进行诊断研究,以及对于腹水治疗高度难治的患者高钠摄入不合适。

相似文献

1
Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid.不限制钠摄入且不完全清除过多液体治疗腹水的优势。
Gut. 1978 Jun;19(6):549-53. doi: 10.1136/gut.19.6.549.
2
Hypernatremia following gastrointestinal bleeding in cirrhosis with ascites.肝硬化腹水患者胃肠道出血后出现高钠血症。
Am J Dig Dis. 1975 Feb;20(2):127-33. doi: 10.1007/BF01072338.
3
Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.高剂量螺内酯治疗慢性肝病伴相对难治性腹水患者的疗效
Am J Dig Dis. 1978 Nov;23(11):1025-30. doi: 10.1007/BF01263103.
4
Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.肝硬化腹水患者的有效血浆容量。有证据表明,有效血浆容量降低并不能解释肾钠潴留、肾小球滤过率(GFR)的自发性降低以及药物诱导利尿期间GFR的下降。
J Clin Invest. 1969 Jun;48(6):975-81. doi: 10.1172/JCI106078.
5
Diuresis of ascites: fraught with or free from hazard.腹水利尿:充满风险还是没有风险。
Gastroenterology. 1977 Sep;73(3):619-21.
6
Complications of diuresis in the alcoholic patient with ascites: a controlled trial.酒精性腹水患者利尿的并发症:一项对照试验。
Gastroenterology. 1977 Sep;73(3):534-8.
7
High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume".继发于“有效血容量”增加的肝硬化患者尿酸和尿素清除率升高。
Am J Med. 1982 Sep;73(3):328-34.
8
Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.慢性肝病腹水患者的快速利尿:外周水肿的重要性。
Gastroenterology. 1986 Jun;90(6):1827-33. doi: 10.1016/0016-5085(86)90249-0.
9
The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve.肝肾综合征与顽固性腹水。采用LeVeen型腹腔-静脉分流术及瓣膜进行成功治疗。
Nephron. 1979;23(5):228-32. doi: 10.1159/000181640.
10
Combined ascitic-fluid and furosemide infusion in the management of ascites.联合腹水和呋塞米输注治疗腹水
N Engl J Med. 1970 Mar 26;282(13):713-7. doi: 10.1056/NEJM197003262821304.

引用本文的文献

1
Impacts of salt restriction on nutritional status, sarcopenia, and mortality of cirrhotic patients with ascites.限盐对肝硬化腹水患者营养状况、肌肉减少症和死亡率的影响。
BMC Gastroenterol. 2025 Jul 15;25(1):521. doi: 10.1186/s12876-025-03830-1.
2
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.终末期肝病中的衰弱:了解病理生理学、评估工具和管理策略。
World J Gastroenterol. 2023 Dec 14;29(46):6028-6048. doi: 10.3748/wjg.v29.i46.6028.
3
Dietary salt in liver cirrhosis: With a pinch of salt!肝硬化中的膳食盐:需谨慎对待!
World J Hepatol. 2023 Oct 27;15(10):1084-1090. doi: 10.4254/wjh.v15.i10.1084.
4
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease.亚太肝脏研究协会肝病腹水管理指南
Hepatol Int. 2023 Aug;17(4):792-826. doi: 10.1007/s12072-023-10536-7. Epub 2023 May 26.
5
Salt consumption and mortality risk in cirrhotic patients: results from a cohort study.肝硬化患者的盐摄入量与死亡率风险:一项队列研究的结果。
J Nutr Sci. 2022 Nov 8;11:e99. doi: 10.1017/jns.2022.69. eCollection 2022.
6
Overview of Complications in Cirrhosis.肝硬化并发症概述
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1150-1174. doi: 10.1016/j.jceh.2022.04.021. Epub 2022 May 14.
7
Management of Ascites in Patients with Cirrhosis: An Update.肝硬化患者腹水的管理:最新进展
J Clin Med. 2021 Nov 10;10(22):5226. doi: 10.3390/jcm10225226.
8
Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians.肝硬化腹水的优化管理:内科医师综述
J Transl Int Med. 2020 Dec 31;8(4):220-236. doi: 10.2478/jtim-2020-0035. eCollection 2020 Dec.
9
Malnutrition in cirrhosis: More food for thought.肝硬化中的营养不良:更多值得思考的问题。
World J Hepatol. 2020 Nov 27;12(11):883-896. doi: 10.4254/wjh.v12.i11.883.
10
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南。
Gut. 2021 Jan;70(1):9-29. doi: 10.1136/gutjnl-2020-321790. Epub 2020 Oct 16.

本文引用的文献

1
An explanation for and experimental correction of the abnormal water diuresis in cirrhosis.肝硬化患者异常水利尿的解释及实验性纠正
J Clin Invest. 1960 Feb;39(2):248-61. doi: 10.1172/JCI104035.
2
Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure.肝硬化和充血性心力衰竭水肿患者的总可交换钠、总可交换钾和总体水
J Clin Invest. 1958 May;37(5):687-98. doi: 10.1172/JCI103655.
3
Compartmentalization of ascites and edema in patients with hepatic cirrhosis.肝硬化患者腹水和水肿的分隔化
N Engl J Med. 1970 Jun 18;282(25):1391-6. doi: 10.1056/NEJM197006182822502.
4
Complications of diuretic therapy in hepatic cirrhosis.
Lancet. 1966 May 14;1(7446):1049-52. doi: 10.1016/s0140-6736(66)91005-1.